Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity

Abstract: Red blood cell (RBC) transfusion therapy in sickle cell disease (SCD) is used to treat and prevent disease complications by providing nonsickle erythrocytes that survive for weeks in circulation. The suppression of sickle hemoglobin between transfusion episodes is dependent on donor RBC su...

Cijeli opis

Bibliografski detalji

Glavni autori:	Marianne E. M. Yee, Patricia E. Zerra, Richard O. Francis, Kirk A. Easley, Christopher M. Lough, James W. McCoy, Zahra Naseh, Bhaveshkumar B. Delvadia, Ashishkumar K. Parikh, Hailly E. Butler, Sean R. Stowell, Clinton H. Joiner, Cassandra D. Josephson, John D. Roback, Ross M. Fasano
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2026-07-01
Serija:	Blood Advances
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2473952926003198
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!